• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药作为一种通过调节肠道菌群治疗结直肠癌的新疗法。

Traditional Chinese medicine as a novel therapy for colorectal cancer by modulating intestinal flora.

作者信息

Dong Yushan, Chen Jingyu, Sun Heng, Chen Yuhan, Jiao Yan, Gu Weikuan, Chen Hong, Liu Songjiang

机构信息

Graduate School of Heilongjiang University of Chinese Medicine, No. 24, Heping Road, Xiangfang District, Harbin, Heilongjiang, China, 150040.

Department of Chinese Medicine Internal Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences, No. 1, Xiyuan Playground, Haidian District, Beijing, 100091.

出版信息

J Cancer. 2023 Sep 4;14(14):2720-2725. doi: 10.7150/jca.87719. eCollection 2023.

DOI:10.7150/jca.87719
PMID:37779871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10539393/
Abstract

Colorectal cancer is a common clinical malignant tumor of the digestive tract, and intestinal flora has played an important role in the development of colorectal cancer. Bifidobacteria, as one of the main dominant florae in intestinal tract, can inhibit the occurrence and development of colorectal cancer through various mechanisms. Recent studies have shown that traditional Chinese medicine can regulate the abundance of bifidobacteria in intestinal tract and exhibit anti-tumor effects on colorectal cancer. Detailed investigations have revealed that the mechanisms of bifidobacteria in the treatment of colorectal cancer involve three aspects: the production of short-chain fatty acids, the regulation of the body's immunity, and the regulation of cell apoptosis and differentiation. In this review, we provide an updated summary of recent advances in our understanding of the mechanisms by which traditional Chinese medicine regulate intestinal flora to inhibit colorectal cancer development and metastasis.

摘要

结直肠癌是临床常见的消化道恶性肿瘤,肠道菌群在结直肠癌的发生发展中发挥着重要作用。双歧杆菌作为肠道内主要的优势菌群之一,可通过多种机制抑制结直肠癌的发生发展。近年来的研究表明,中药可调节肠道内双歧杆菌的丰度,并对结直肠癌发挥抗肿瘤作用。详细研究发现,双歧杆菌治疗结直肠癌的机制涉及三个方面:产生短链脂肪酸、调节机体免疫以及调节细胞凋亡和分化。在本综述中,我们对中药调节肠道菌群以抑制结直肠癌发生发展和转移的机制的最新研究进展进行了更新总结。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89cd/10539393/e0415d16d417/jcav14p2720g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89cd/10539393/8ae29ee1b62f/jcav14p2720g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89cd/10539393/eb1394baca29/jcav14p2720g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89cd/10539393/e0415d16d417/jcav14p2720g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89cd/10539393/8ae29ee1b62f/jcav14p2720g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89cd/10539393/eb1394baca29/jcav14p2720g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89cd/10539393/e0415d16d417/jcav14p2720g003.jpg

相似文献

1
Traditional Chinese medicine as a novel therapy for colorectal cancer by modulating intestinal flora.中药作为一种通过调节肠道菌群治疗结直肠癌的新疗法。
J Cancer. 2023 Sep 4;14(14):2720-2725. doi: 10.7150/jca.87719. eCollection 2023.
2
The triangular relationship between traditional Chinese medicines, intestinal flora, and colorectal cancer.中药、肠道菌群与结直肠癌的三角关系。
Med Res Rev. 2024 Mar;44(2):539-567. doi: 10.1002/med.21989. Epub 2023 Sep 3.
3
Phytochemicals in traditional Chinese medicine can treat gout by regulating intestinal flora through inactivating NLRP3 and inhibiting XOD activity.中药中的植物化学物质可以通过抑制 NLRP3 和 XOD 活性来调节肠道菌群,从而治疗痛风。
J Pharm Pharmacol. 2022 Jul 15;74(7):919-929. doi: 10.1093/jpp/rgac024.
4
Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology.中医药:通过肠道微生态调节溃疡性结肠炎细菌菌群失衡、肠屏障损伤及免疫功能紊乱的策略
J Ethnopharmacol. 2024 Jan 10;318(Pt A):116879. doi: 10.1016/j.jep.2023.116879. Epub 2023 Jul 5.
5
A network meta-analysis to evaluate the efficacy of traditional Chinese medicine on intestinal flora in patients with gastrointestinal cancer.一项评估中药对胃肠道癌症患者肠道菌群疗效的网状Meta分析。
Front Genet. 2022 Nov 28;13:1069780. doi: 10.3389/fgene.2022.1069780. eCollection 2022.
6
Considering traditional Chinese medicine as adjunct therapy in the management of chronic constipation by regulating intestinal flora.考虑将中药作为辅助疗法,通过调节肠道菌群来治疗慢性便秘。
Biosci Trends. 2024 Jun 6;18(2):127-140. doi: 10.5582/bst.2024.01036. Epub 2024 Mar 25.
7
Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora.小檗碱通过重塑肠道菌群来调节短链脂肪酸代谢,缓解结肠炎相关结直肠肿瘤的发生。
Phytomedicine. 2022 Jul 20;102:154217. doi: 10.1016/j.phymed.2022.154217. Epub 2022 May 27.
8
[Role of gut microbiota in carcinogenesis and treatment for colorectal cancer].[肠道微生物群在结直肠癌发生及治疗中的作用]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 May 25;23(5):516-520. doi: 10.3760/cma.j.cn.441530-20190820-00314.
9
[Weidiao-3 Mixture Improves the Clinical Efficacy of Immunotherapy for Advanced Gastric Cancer by Regulating Intestinal Flora].[萎凋-3合剂通过调节肠道菌群提高晚期胃癌免疫治疗的临床疗效]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023 Aug;45(4):581-590. doi: 10.3881/j.issn.1000-503X.15496.
10
Advancement of Traditional Chinese Medicine in Regulation of Intestinal Flora: Mechanism-based Role in Disease Management.中医药在调节肠道菌群方面的进展:基于机制在疾病管理中的作用
Recent Pat Anticancer Drug Discov. 2022;17(2):136-144. doi: 10.2174/1574892816666210929164930.

引用本文的文献

1
Chinese Medicine in Colorectal Cancer Treatment: From Potential Targets and Mechanisms to Clinical Application.中医在结直肠癌治疗中的应用:从潜在靶点与机制到临床应用
Chin J Integr Med. 2024 Sep 27. doi: 10.1007/s11655-024-4115-8.

本文引用的文献

1
Advances on anticancer new drugs in China and the USA in 2020: from ongoing trial to drug approval.2020年中美两国抗癌新药进展:从临床试验到药物获批
J Natl Cancer Cent. 2021 Aug 22;1(4):147-152. doi: 10.1016/j.jncc.2021.08.002. eCollection 2021 Dec.
2
Cancer incidence and mortality in China, 2016.2016年中国癌症的发病率和死亡率
J Natl Cancer Cent. 2022 Feb 27;2(1):1-9. doi: 10.1016/j.jncc.2022.02.002. eCollection 2022 Mar.
3
Gut microbiota and colorectal cancer metastasis.肠道微生物群与结直肠癌转移
Cancer Lett. 2023 Feb 28;555:216039. doi: 10.1016/j.canlet.2022.216039. Epub 2022 Dec 15.
4
Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.肠道微生物群对结直肠癌免疫反应和免疫治疗的影响。
Front Immunol. 2022 Nov 8;13:1030745. doi: 10.3389/fimmu.2022.1030745. eCollection 2022.
5
Metabolic regulation of immune responses to cancer.癌症免疫反应的代谢调控。
Cancer Biol Med. 2022 Oct 24;19(11):1528-42. doi: 10.20892/j.issn.2095-3941.2022.0381.
6
Therapeutic approaches to colorectal cancer strategies based on modulation of gut microbiota.基于肠道微生物群调节的结直肠癌治疗方法 策略
Front Microbiol. 2022 Aug 4;13:945533. doi: 10.3389/fmicb.2022.945533. eCollection 2022.
7
Mechanisms by Which Traditional Chinese Medicines Influence the Intestinal Flora and Intestinal Barrier.中药影响肠道菌群和肠道屏障的机制。
Front Cell Infect Microbiol. 2022 Apr 28;12:863779. doi: 10.3389/fcimb.2022.863779. eCollection 2022.
8
Surgical site infection after laparoscopic resection of colorectal cancer is associated with compromised long-term oncological outcome.结直肠肿瘤腹腔镜手术后手术部位感染与长期肿瘤学预后不良有关。
World J Surg Oncol. 2022 Apr 7;20(1):111. doi: 10.1186/s12957-022-02578-2.
9
Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer.真实世界数据:呋喹替尼治疗转移性结直肠癌。
Oncol Res. 2022 May 4;29(1):25-31. doi: 10.3727/096504022X16427607626672. Epub 2022 Jan 21.
10
Gut Microbiota: A Potential Target for Cancer Interventions.肠道微生物群:癌症干预的潜在靶点。
Cancer Manag Res. 2021 Nov 3;13:8281-8296. doi: 10.2147/CMAR.S328249. eCollection 2021.